CLOSE X
GO

Nippon India Pharma Fund(G)

very highequitypharma & health care
514.77 1.33(0.26%) NAV as on 25 Nov 2025
0.15 % 1 M
0.84 % 1 Y
21.35 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.80

As on 31 Oct, 2025
age-icon Age :

21 yrs 5 m

Since 05 06 ,2004
exit_load Exit Load :

1%

aum AUM :

8,346.49 Crs

lock_in Lock-in :

1% on or before 1M, Nil after 1M

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

8.2

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Sailesh Raj Bhan

LATEST ASSET & PORTFOLIO ALLOCATION

as on Oct 31 ,2025
Others 0.34 %
Equity 99.66 %

TOP HOLDINGS

Sun Pharmaceutical Industries...12.67 %
Divi's Laboratories Ltd.8.07 %
Lupin Ltd.7.26 %
Cipla Ltd.6.29 %
Apollo Hospitals Enterprise Ltd.5.97 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs75.07
Hospital & Healthcare Services20.28
Retailing3.32
Business Support1.00
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)250.18290.14270.59428.87481.27
Net Assets(Rs Crores) (as on 31-Mar-2025) 4260.99 4931.89 4304.46 7125.28 8080.97
Scheme Returns(%)(Absolute)77.3614.83-6.8558.2410.94
B'mark Returns(%)(Absolute)NANANANANA
Category Rank32/7543/7565/7617/9030/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Nippon India Pharma Fund(G)Very HighEquity514.771.33(0.26%)NAV As on 25 Nov, 202505-Jun-2004Inception Date8,346.49AUM In Cr.0.84%1Y21.35%3Y17.19%5Y20.13%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity40.110.21(0.53%)NAV As on 25 Nov, 202513-Jul-2018Inception Date6,437.36AUM In Cr.5.36%1Y26.93%3Y20.05%5Y20.72%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity431.47-0.01(0.00%)NAV As on 25 Nov, 202514-Jul-1999Inception Date4,082.13AUM In Cr.1.87%1Y23.84%3Y18.88%5Y16.06%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors